{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:43:52Z","timestamp":1792604632583,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007554","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T00:00:00Z","timestamp":1395878400000}}],"reference-count":213,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007554.pub2","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T23:03:30Z","timestamp":1395875010000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Biocompatible dialysis fluids for peritoneal dialysis"],"prefix":"10.1002","author":[{"given":"Yeoungjee","family":"Cho","sequence":"first","affiliation":[{"name":"Princess Alexandra Hospital; Department of Nephrology; ARTS Building Ipswich Rd Woolloongabba Queensland Australia 4012"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[{"name":"Princess Alexandra Hospital; Department of Nephrology; ARTS Building Ipswich Rd Woolloongabba Queensland Australia 4012"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Craig","sequence":"additional","affiliation":[{"name":"The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006"},{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni FM","family":"Strippoli","sequence":"additional","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"},{"name":"University of Bari; Department of Emergency and Organ Transplantation; Bari Italy"},{"name":"Diaverum; Medical Scientific Office; Lund Sweden"},{"name":"Diaverum Academy; Bari Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil V","family":"Badve","sequence":"additional","affiliation":[{"name":"Princess Alexandra Hospital; Department of Nephrology; ARTS Building Ipswich Rd Woolloongabba Queensland Australia 4012"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J","family":"Wiggins","sequence":"additional","affiliation":[{"name":"Royal Melbourne Hospital; Departments of Nephrology and General Medicine; Melbourne VIC Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/gfq357","article-title":"Low-GDP peritoneal dialysis fluid ('balance') has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid","volume":"26","author":"Bajo","year":"2011","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/089686080602600120","article-title":"A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients","volume":"26","author":"Brown","year":"2006","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2011121201","article-title":"Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes","volume":"23","author":"Johnson","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2369-11-25","article-title":"Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function","volume":"11","author":"Johnson","year":"2010","journal-title":"BMC Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/089686080602600121","article-title":"A randomized controlled trial to determine whether treatment with at neutral pH, low glucose degradation product dialysate (balance) prolongs residual renal function in peritoneal dialysis patients","volume":"26","author":"Woodrow","year":"2006","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0007|cit6","first-page":"A11","article-title":"Effects on peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism","volume":"58","author":"Bredie","year":"2001","journal-title":"Netherlands Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0006|cit7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/089686080102100308","article-title":"Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism","volume":"21","author":"Bredie","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"Sept","key":"10.1002\/14651858.CD007554.pub2-BIB0008|cit8","first-page":"203A","article-title":"Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism [abstract]","volume":"11","author":"Bredie","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/089686089801800604","article-title":"Clinical evaluation of a peritoneal dialysis solution with 33 mmol\/L bicarbonate","volume":"18","author":"Cancarini","year":"1998","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/089686080102100603","article-title":"Acidosis correction with a new 25 mmol\/l bicarbonate\/15 mmol\/l lactate peritoneal dialysis solution","volume":"21","author":"Carrasco","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007554.pub2-BIB0011|cit11","first-page":"iv254","article-title":"The clinical impacts of novel peritoneal dialysis fluids (PDFs) with neutral pH and low glucose degradation product (GDP) concentration (Balance\u00ae) [abstract no: SP708]","volume":"21","author":"Choi","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/089686080802800214","article-title":"The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial","volume":"28","author":"Choi","year":"2008","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0013|cit13","first-page":"112A","article-title":"The clinical usefulness of peritoneal dialysis fluids (PDFs) with neutral pH and low glucose degradation product (GDP) Concentration-Balance\u00ae [abstract no: SA-FC138]","volume":"16","author":"Lee","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3747\/pdi.2010.00009","article-title":"The influence of bicarbonate\/lactate-buffered PD fluids on N\u0190-(carboxyethyl)lysine and N\u0190-(carboxymethyl)lysine in peritoneal effluent","volume":"31","author":"Cnossen","year":"2011","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/089686089701700111","article-title":"A randomized controlled trial of a bicarbonate- and a bicarbonate\/lactate-containing dialysis solution in CAPD","volume":"17","author":"Coles","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"12","key":"10.1002\/14651858.CD007554.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/ndt\/13.12.3165","article-title":"A controlled trial of two bicarbonate-containing dialysis fluids for CAPD--final report","volume":"13","author":"Coles","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0272-6386(00)70309-X","article-title":"In vivo exposure to bicarbonate\/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function","volume":"35","author":"Mackenzie","year":"2000","journal-title":"American Journal of Kidney Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007554.pub2-BIB0018|cit18","first-page":"S408","article-title":"In vivo exposure to bicarbonate\/lactate-buffered pdf (tbl) improves ex vivo pmo function, compared to bicarbonate-(tb) or lactate-buffered pdf (pd4) [abstract]","volume":"3","author":"Topley","year":"1997","journal-title":"Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0019|cit19","first-page":"292A","article-title":"Long-term in vivo exposure to bicarbonate\/lactate dialysis fluid improves ex vivo peritoneal macrophage (PMO) TNFa secretion [abstract]","volume":"9","author":"Williams","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD007554.pub2-BIB0020|cit20","first-page":"156A","article-title":"Increasing our understanding of the mechanism of action of icodextrin (ICO) [abstract no: F-PO407]","volume":"15","author":"Davies","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007554.pub2-BIB0021|cit21","first-page":"17","article-title":"Icodextrin improves fluid balance in PD patients [abstract no: O52]","volume":"17","author":"Davies","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/01.ASN.0000083904.12234.27","article-title":"Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial","volume":"14","author":"Davies","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub2-BIB0023|cit23","first-page":"632A","article-title":"Icodextrin improves fluid status in PD patients [abstract no: SU-PO798]","volume":"13","author":"Davies","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Sept","key":"10.1002\/14651858.CD007554.pub2-BIB0024|cit24","first-page":"206A","article-title":"Cardiovascular and hemodynamic profile related to hypotensive effect long term of icodextrine (ico) in CAPD patients [abstract]","volume":"11","author":"Paolo","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0025|cit25","first-page":"476A","article-title":"Decline of residual renal function (RRF) in peritoneal dialysis (PD) patients (pts) depends on uptake of carbonyl compounds (CC) from the peritoneal cavity: first data of a prospective clinical trial [abstract]","volume":"14","author":"Haag-Weber","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1093\/ndt\/gfq087","article-title":"Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study","volume":"25","author":"Haag-Weber","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub2-BIB0027|cit27","first-page":"199A","article-title":"Treatment with low GDP solution (CAPD balance) is associated with an increase in effluent CA125 and a decrease in HA content: data from the multi centre European Balance Trial [abstract no: F-P0685]","volume":"13","author":"Mackenzie","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0028|cit28","first-page":"101","article-title":"Continuous treatment with low GDP solution (CAPD Balance\u00ae) is associated with an increase in effluent CA125 and a decrease in HA content: data from the Multicenter European Balance Trial [abstract]","volume":"22","author":"Mackenzie","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub2-BIB0029|cit29","first-page":"199A","article-title":"Reduced systemic AGE formation with a low GDP solution (CAPD balance): data from the multicentre European Balance Trial [abstract no: F-PO683]","volume":"13","author":"Williams","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1523-1755.2004.00747.x","article-title":"The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane","volume":"66","author":"Williams","year":"2004","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/ndt\/gfh013","article-title":"Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells","volume":"19","author":"Witowski","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.ki.5002574","article-title":"Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function","volume":"73","author":"Fan","year":"2008","journal-title":"Kidney International"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ki.2011.244","article-title":"Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival","volume":"80","author":"Srivastava","year":"2011","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1046\/j.1523-1755.1998.00167.x","article-title":"Randomized long-term evaluation of bicarbonate-buffered CAPD solution","volume":"54","author":"Feriani","year":"1998","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0035|cit35","first-page":"414","article-title":"An open controlled randomized clinical trial with bicarbonate CAPD solutions: interim results [abstract]","volume":"5","author":"Feriani","year":"1994","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0036|cit36","first-page":"A253","article-title":"Long term safety and efficacy of bicarbonate buffered peritoneal dialysis solutions [abstract]","volume":"11","author":"Feriani","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD007554.pub2-BIB0037|cit37","first-page":"S82","article-title":"Experiences with bicarbonate solutions in peritoneal dialysis","volume":"23","author":"Passlick-Deetjen","year":"1994","journal-title":"Nieren-und Hochdruckkrankheiten"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0038|cit38","first-page":"iii477","article-title":"Effects of bicavera (BV) dialysate for peritoneal dialysis on the epithelial-to-mesenchymal transition (EMT) of the mesothelial cell (MC) ex vivo [abstract]","volume":"3","author":"Fernandez Perpen","year":"2010","journal-title":"NDT Plus"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3747\/pdi.2010.00315","article-title":"Influence of bicarbonate\/low-GDP peritoneal dialysis fluid (Bicavera) on in vitro and ex vivo epithelial-to-mesenchymal transition of mesothelial cells","volume":"32","author":"Fernandez-Perpen","year":"2012","journal-title":"Peritoneal Dialysis International"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1681\/ASN.2004090793","article-title":"Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration","volume":"16","author":"Finkelstein","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007554.pub2-BIB0041|cit41","first-page":"214","article-title":"Biocompatibility pattern of neutral bicarbonate\/lactate buffered peritoneal dialysis solution in chronic APD patients - a prospective; randomized; cross over study [abstract]","volume":"18","author":"Fusshoeller","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"8","key":"10.1002\/14651858.CD007554.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1093\/ndt\/gfh326","article-title":"Biocompatibility pattern of a bicarbonate\/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study","volume":"19","author":"Fusshoeller","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub2-BIB0043|cit43","first-page":"41A","article-title":"Local and systemic effects of neutral pH, low GDP dialysate in CAPD patients [abstract no: SA-FC202]","volume":"13","author":"Do","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD007554.pub2-BIB0044|cit44","first-page":"375A","article-title":"The effect of neutral pH, low GDPs dialysis solution on fluid, solute transport and edema control in CAPD patients [abstract no: SA-PO337]","volume":"15","author":"Do","year":"2004","journal-title":"Journal of American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1177\/089686080502503S06","article-title":"The effect of low glucose degradation product dialysis solution on epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis patients","volume":"25 Suppl 3","author":"Do","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"Nov","key":"10.1002\/14651858.CD007554.pub2-BIB0046|cit46","first-page":"479A","article-title":"Effects of low glucose degradation products (GDPs) dialysis solution on the levels of surrogate markers of peritoneal inflammation, integrity and angiogenesis. Preliminary Report [abstract no: SA-PO822]","volume":"14","author":"Kim","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1046\/j.1440-1797.8.s.6.x","article-title":"Low glucose degradation products dialysis solution modulates the levels of surrogate markers of peritoneal inflammation, integrity, and angiogenesis: preliminary report","volume":"8 Suppl","author":"Kim","year":"2003","journal-title":"Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD007554.pub2-BIB0048|cit48","first-page":"374A","article-title":"The effect of low GDPs solution on peritoneal fibrosis markers [abstract no: SA-PO333]","volume":"15","author":"Park","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD007554.pub2-BIB0049|cit49","first-page":"278A","article-title":"Clinical benefits of a low glucose degradation products solution in patients starting peritoneal dialysis: preliminary report [abstract no: TH-PO809]","volume":"17","author":"Kim","year":"2006","journal-title":"Journal of American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/ndt\/gfp054","article-title":"Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study","volume":"24","author":"Kim","year":"2009","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1177\/089686080802803s22","article-title":"Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet study)","volume":"28 Suppl 3","author":"Kim","year":"2008","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0052|cit52","first-page":"iii175","article-title":"Effect of biocompatible PD fluid on preservation of residual renal function in incident CAPD patients: two-year extended follow-up study [abstract no: SA418]","volume":"3","author":"Kim","year":"2010","journal-title":"NDT Plus"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1046\/j.1523-1755.2003.00887.x","article-title":"Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study","volume":"63","author":"Konings","year":"2003","journal-title":"Kidney International"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub2-BIB0054|cit54","first-page":"206a","article-title":"Effect of icodextrin on volume status, blood pressure and echocardiographic parameters [abstract no: F-PO719]","volume":"13","author":"Konings","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1177\/089686080502500616","article-title":"Influence of icodextrin on plasma and dialysate levels of N\u0190-(carboxymethyl)lysine and N\u0190-(carboxyethyl)lysine","volume":"25","author":"Konings","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/089686080602600322","article-title":"The increase in plasma levels of N\u0190-(carboxymethyl)lysine during icodextrin treatment of peritoneal dialysis patients is not associated with increased plasma levels of vascular cell adhesion molecule-1","volume":"26","author":"Kooman","year":"2006","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3747\/pdi.2010.00176","article-title":"A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products","volume":"32","author":"Lai","year":"2012","journal-title":"Peritoneal Dialysis International"},{"issue":"11","key":"10.1002\/14651858.CD007554.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2215\/CJN.02950509","article-title":"Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid","volume":"4","author":"Lin","year":"2009","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1523-1755.1998.00849.x","article-title":"Bicarbonate and bicarbonate\/lactate peritoneal dialysis solutions for the treatment of infusion pain","volume":"53","author":"Mactier","year":"1998","journal-title":"Kidney International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0060|cit60","first-page":"273A","article-title":"Treatment of infusion pain (InP) with novel bicarbonate containing PD solutions [abstract]","volume":"8","author":"Sprosen","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0061|cit61","first-page":"A240","article-title":"Reduction in the prevalence of CAPD symptoms during 6 months treatment with icodextrin [abstract]","volume":"11","author":"Armstrong","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/089686089501500309","article-title":"Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis","volume":"15","author":"Gokal","year":"1995","journal-title":"Peritoneal Dialysis International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0063|cit63","first-page":"283A","article-title":"Improvement of hyperlipidemia with icodextrin use in CAPD patients [abstract]","volume":"9","author":"Gokal","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ki.1994.300","article-title":"A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis","volume":"46","author":"Mistry","year":"1994","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/ndt\/gfn673","article-title":"Short-term effects of bicarbonate\/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study","volume":"24","author":"Pajek","year":"2009","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/089686080802800109","article-title":"Short-term effects of a new bicarbonate\/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study","volume":"28","author":"Pajek","year":"2008","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1744-9987.2009.00717.x","article-title":"Cell-free DNA in the peritoneal effluent of peritoneal dialysis solutions","volume":"14","author":"Pajek","year":"2010","journal-title":"Therapeutic Apheresis & Dialysis"},{"issue":"108","key":"10.1002\/14651858.CD007554.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1038\/sj.ki.5002613","article-title":"Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis","author":"Paniagua","year":"2008","journal-title":"Kidney International - Supplement"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/089686080902900409","article-title":"Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients","volume":"29","author":"Paniagua","year":"2009","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/ajkd.2002.32009","article-title":"Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis","volume":"39","author":"Plum","year":"2002","journal-title":"American Journal of Kidney Diseases"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/089686080002000203","article-title":"Peritoneal kinetics and mesothelial markers in CCPD using icodextrin for daytime dwell for two years","volume":"20","author":"Posthuma","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/089686089901900409","article-title":"Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients","volume":"19","author":"Posthuma","year":"1999","journal-title":"Peritoneal Dialysis International"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0082|cit73","first-page":"A184","article-title":"Icodextrin (I) use in CCPD patients during peritonitis: serum disaccharide levels and ultrafiltration (UF) [abstract]","volume":"12","author":"Posthuma","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0073|cit74","first-page":"223A","article-title":"Ex vivo peritoneal defense characteristics and peritonitis rate in CCPD patients using glucose or icodextrin as daytime dwell [abstract]","volume":"9","author":"Posthuma","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0074|cit75","first-page":"513","article-title":"Disaccharide (\"total maltose\") levels in CCPD patients using icodextrin [abstract]","volume":"6","author":"Posthuma","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0075|cit76","first-page":"S106","article-title":"Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group","volume":"20 Suppl 2","author":"Posthuma","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0076|cit77","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/089686089701700613","article-title":"Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell","volume":"17","author":"Posthuma","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0077|cit78","first-page":"270A","article-title":"Icodextrin (I) use in CCPD patients during peritonitis: serum disaccharide (maltose) levels and ultrafiltration (UF) [abstract]","volume":"8","author":"Posthuma","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0078|cit79","first-page":"513","article-title":"Improved ultrafiltration in CCPD patients using icodextrin (I) instead of glucose (G) for the long daytime dwell [abstract]","volume":"6","author":"Posthuma","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0079|cit80","first-page":"223A","article-title":"Peritoneal membrane characteristics in CCPD patients using glucose or icodextrin as daytime dwell [abstract]","volume":"9","author":"Posthuma","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0080|cit81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/089686080102100107","article-title":"Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin","volume":"21","author":"Posthuma","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0081|cit82","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ndt\/12.3.550","article-title":"Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance","volume":"12","author":"Posthuma","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1093\/ndt\/13.9.2341","article-title":"Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations","volume":"13","author":"Posthuma","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0084|cit84","first-page":"A180","article-title":"More Ca125 in dialysate after long-term treatment with a new, less toxic PD-fluid (PD-bio) [abstract]","volume":"12","author":"Rippe","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0085|cit85","first-page":"182A","article-title":"Patient dialysate CA 125 and hyaluronan (HA) after 1, 6 and 12 months of treatment with a PD-fluid containing less cytotoxic glucose degradation products [abstract]","volume":"8","author":"Rippe","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1046\/j.1523-1755.2001.00497.x","article-title":"Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products","volume":"59","author":"Rippe","year":"2001","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0088|cit87","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1177\/089686080102103S20","article-title":"Biologic significance of reduced levels of glucose degradation products","volume":"21 Suppl 3","author":"Rippe","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"140","key":"10.1002\/14651858.CD007554.pub2-BIB0087|cit88","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000071423","article-title":"Long-term results with low glucose degradation product content in peritoneal dialysis fluids","author":"Rippe","year":"2003","journal-title":"Contributions to Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD007554.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1097\/01.ASN.0000086475.83211.DF","article-title":"Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis","volume":"14","author":"Haas","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl","key":"10.1002\/14651858.CD007554.pub2-BIB0090|cit90","first-page":"C53","article-title":"Randomized cross-over evaluation of bicarbonate-vs lactate buffered PD solutions in children on APD [abstract]","volume":"17","author":"Haas","year":"2002","journal-title":"Pediatric Nephrology"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub2-BIB0091|cit91","first-page":"202A","article-title":"Better biocompatibility and correction of acidosis using bicarbonate vs lactate buffered PD fluid in children on APD: a randomized cross-over clinical trial [abstract]","volume":"13","author":"Haas","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 12","key":"10.1002\/14651858.CD007554.pub2-BIB0092|cit92","first-page":"17","article-title":"Randomized cross-over administration of pH-neutral, bicarbonate buffered PD solution in children on APD [abstract no: O51]","volume":"17","author":"Schmitt","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0093|cit93","first-page":"193A","article-title":"Comparison of solute and acid-base transport kinetics in children using bicarbonate- vs. lactate-buffered PD solutions [abstract]","volume":"9","author":"Schmitt","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1046\/j.1523-1755.2002.00255.x","article-title":"Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children","volume":"61","author":"Schmitt","year":"2002","journal-title":"Kidney International"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/ndt\/gfm148","article-title":"Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content","volume":"22","author":"Schmitt","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ndt\/gfl559","article-title":"Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial","volume":"22","author":"Szeto","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2215\/CJN.10041110","article-title":"Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial","volume":"6","author":"Takatori","year":"2011","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1177\/089686080102103S17","article-title":"Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate\/lactate-based peritoneal dialysis solutions","volume":"21 Suppl 3","author":"Cooker","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0099|cit99","first-page":"264A","article-title":"Bicarbonate\/lactate-buffered (TBL) peritoneal dialysis fluid (PDF) decreases pro-collagen I levels in peritoneal dialysis effluent (PDE) [abstract no: A1214]","volume":"8","author":"Holmes","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.1523-1755.2001.0590041529.x","article-title":"Bicarbonate\/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels","volume":"59","author":"Jones","year":"2001","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1681\/ASN.V13suppl_1s97","article-title":"Continuous dialysis with bicarbonate\/lactate-buffered peritoneal dialysis fluids results in a long-term improvement in ex vivo peritoneal macrophage function","volume":"13 Suppl 1","author":"Jones","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0102|cit102","first-page":"290A","article-title":"In vivo exposure to bicarbonate\/lactate-buffered (TBL) peritoneal dialysis fluid (PDF) decreases pro-collagen I and TGF-b1 (TGF-b1) levels in peritoneal dialysis effluent (PDE) [abstract]","volume":"9","author":"Topley","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0103|cit103","first-page":"230A","article-title":"Peritoneal dialysate CA125, hyaluronan (HA), TGFb1 and pro-collagen I peptide (PICP) in a randomized, controlled study of bicarbonate\/lactate based CAPD solution. [abstract no: A1169]","volume":"10","author":"Topley","year":"1999","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/089686080002000506","article-title":"A long-term study of a bicarbonate\/lactate-based peritoneal dialysis solution--clinical benefits. The Bicarbonate\/Lactate Study Group","volume":"20","author":"Tranaeus","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/089686080902900610","article-title":"Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution","volume":"29","author":"Weiss","year":"2009","journal-title":"Peritoneal Dialysis International"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub2-BIB0106|cit106","first-page":"667","article-title":"Quality of life of peritoneal dialysis patients on icodextrin: a longitudinal study [abstract]","volume":"11","author":"Guo","year":"2002","journal-title":"Quality of Life Research"},{"issue":"81","key":"10.1002\/14651858.CD007554.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1046\/j.1523-1755.62.s81.10.x","article-title":"Early quality of life benefits of icodextrin in peritoneal dialysis","author":"Guo","year":"2002","journal-title":"Kidney International - Supplement"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0108|cit108","first-page":"317A","article-title":"One year results-icodextrin vs dextrose for the long dwell in peritoneal dialysis [abstract]","volume":"12","author":"Wolfson","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD007554.pub2-BIB0109|cit109","first-page":"317A","article-title":"Effects of icodextrin on ultrafiltration (UF) and small solute clearance in continuous ambulatory dialysis patients (CAPD) [abstract]","volume":"12","author":"Wolfson","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/ajkd.2002.36344","article-title":"A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis","volume":"40","author":"Wolfson","year":"2002","journal-title":"American Journal of Kidney Diseases"},{"issue":"Sept","key":"10.1002\/14651858.CD007554.pub2-BIB0111|cit111","first-page":"223A","article-title":"Resorption of age-promoting glucose degradation products (GDP) from peritoneal dialysis (PD) fluids leads to increased levels of age in plasma [abstract]","volume":"11","author":"Zeier","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1523-1755.2003.00705.x","article-title":"Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?","volume":"63","author":"Zeier","year":"2003","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2369-5-14","article-title":"BIOKID: Randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991]","volume":"5","author":"Nau","year":"2004","journal-title":"BMC Nephrology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD007554.pub2-BIB0114|cit114","first-page":"A414","article-title":"Improved fluid volume and blood pressure status in a contemporary PD population using APD and icodextrin [abstract no: PS130]","volume":"10","author":"Boudville","year":"2005","journal-title":"Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ndt\/gfn452","article-title":"Citrate supplementation of PD fluid: effects on net ultrafiltration and clearance of small solutes in single dwells","volume":"24","author":"Braide","year":"2009","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/089686080402400613","article-title":"Enhanced ultrafiltration using 7.5% icodextrin\/1.36% glucose combination dialysate: a pilot study","volume":"24","author":"Dallas","year":"2004","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0272-6386(12)80270-8","article-title":"Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid","volume":"21","author":"Fijter","year":"1993","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/089686080802800108","article-title":"Comparison between bicarbonate\/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study","volume":"28","author":"Fang","year":"2008","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/ndt\/gfg518","article-title":"Effect of peritoneal dialysis fluid composition on peritoneal area available for exchange in children","volume":"19","author":"Fischbach","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0120|cit120","first-page":"758","article-title":"Comparison of peritoneal equilibrium test with icodextrin and 2.5% glucose dialysis solutions","volume":"19","author":"Hwang","year":"2006","journal-title":"Journal of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0121|cit121","first-page":"114","article-title":"Sodium and water clearance during peritoneal dwells with a novel combination dialysate (1.36% glucose\/7.5% Icodextrin) [abstract]","volume":"22","author":"Jenkins","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/089686080302300513","article-title":"An exploratory study of a novel peritoneal combination dialysate (1.36% glucose\/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone","volume":"23","author":"Jenkins","year":"2003","journal-title":"Peritoneal Dialysis International"},{"issue":"108","key":"10.1002\/14651858.CD007554.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1038\/sj.ki.5002612","article-title":"Effects of peritoneal dialysis fluid biocompatibility on baroreflex sensitivity","author":"John","year":"2008","journal-title":"Kidney International - Supplement"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0124|cit124","unstructured":"La Milia V Crepaldi M Di Filippo S Marai P Locatelli F Effect of pH and glucose concentration on sodium (Na) balances (MB) and on dialysate\/plasma ratio (D\/P) of Na during peritoneal equilibration test (PET) [abstract] 36th Congress European Renal Association, European Dialysis and Transplantation Association; 1999 Sept 5-8; Madrid, Spain 1999 320"},{"issue":"Nov","key":"10.1002\/14651858.CD007554.pub2-BIB0125|cit125","first-page":"478A","article-title":"PD regimen contributes to the blood concentration of glucose degradation products (GDP) in new CAPD patients [abstract no: SA-PO820]","volume":"14","author":"Poole","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD007554.pub2-BIB0126|cit126","first-page":"214","article-title":"The effects of a high-versus low-glucose regime on cell recruitment and biomarkers of CAPD patients. A multi-center, prospective cross-over study [abstract]","volume":"18","author":"Welten","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0127|cit127","first-page":"111","article-title":"Biocompatibility of high versus low glucose regime on peritoneal cells of CAPD patients in a multicenter cross-over study [abstract]","volume":"22","author":"Welten","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub2-BIB0128|cit128","first-page":"202A","article-title":"Biocompatibility of high- versus low-glucose regime on peritoneal cells of CAPD patients in a multi-centered cross-over study [abstract no: F-PO698]","volume":"13","author":"Welten","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub2-BIB0129|cit129","first-page":"200A","article-title":"Clinical effects of a PD regimen low in glucose and GDP's (LG) compared to a standard PD regimen (SPD) in newly CAPD patients [abstract no: F-PO688]","volume":"13","author":"Poole","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub2-BIB0130|cit130","first-page":"200A","article-title":"Outcome of routine laboratory data after 30 weeks of treatment with a PD regimen low in glucose and GDPs (LG) or a standard PD regimen (SPD) in newly CAPD patients [abstract no: F-PO689]","volume":"13","author":"Poole","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1177\/089686080502503S16","article-title":"Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious","volume":"25 Suppl 3","author":"Poole","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3747\/pdi.2010.00115","article-title":"A peritoneal dialysis regimen low in glucose and glucose degradation products results in increased cancer antigen 125 and peritoneal activation","volume":"32","author":"Poole","year":"2012","journal-title":"Peritoneal Dialysis International"},{"issue":"Oct","key":"10.1002\/14651858.CD007554.pub2-BIB0133|cit133","first-page":"375A","article-title":"Peritoneal dialysis regimen low in glucose and GDPs results in lower plasma pentosidine levels [abstract no: SA-PO338]","volume":"15","author":"Poole","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3747\/pdi.2010.00101","article-title":"\"NEPP\" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO","volume":"32","author":"Poole","year":"2012","journal-title":"Peritoneal Dialysis International"},{"issue":"Nov","key":"10.1002\/14651858.CD007554.pub2-BIB0135|cit135","first-page":"478A","article-title":"Clinical effects of PD regimens high or low in glucose and GDP's in a one year multi-center randomized cross-over trial [abstract no: SA-PO819]","volume":"14","author":"Poole","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Oct","key":"10.1002\/14651858.CD007554.pub2-BIB0136|cit136","first-page":"159A","article-title":"Higher markers of endothelial activation during treatment with an alternative peritoneal dialysis solution regimen low in glucose and GDPs (NEPP) [abstract no: F-PO423]","volume":"15","author":"Poole","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Nov","key":"10.1002\/14651858.CD007554.pub2-BIB0137|cit137","first-page":"478A","article-title":"Metabolic effects of PD regimens high or low in glucose and GDP's in a one year multi-center randomized cross-over trial [abstract no: SA-PO818]","volume":"14","author":"Poole","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0138|cit138","first-page":"170","article-title":"Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study","volume":"20","author":"Poole","year":"2004","journal-title":"Advances in Peritoneal Dialysis"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0139|cit139","first-page":"110A","article-title":"Low glucose\/GDP dialysis regimen results in increased mesothelial regeneration and vascular permeability [abstract no: SA-FC129]","volume":"16","author":"Ittersum","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/089686080202200604","article-title":"Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid","volume":"22","author":"Liberek","year":"2002","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/089686080502500509","article-title":"Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?","volume":"25","author":"Martikainen","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/089686080702700617","article-title":"Does the biocompatibility of the peritoneal dialysis solution matter in assessment of peritoneal function?","volume":"27","author":"Parikova","year":"2007","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000183338","article-title":"Acetate versus lactate in peritoneal dialysis solutions","volume":"39","author":"Pedersen","year":"1985","journal-title":"Nephron"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/089686089701702S13","article-title":"Icodextrin plus glucose combinations for use in CAPD","volume":"17 Suppl 2","author":"Peers","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1046\/j.1523-1755.2002.00276.x","article-title":"Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle","volume":"61","author":"Pickering","year":"2002","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/089686089901900504","article-title":"An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose\/bicarbonate and glucose\/lactate solutions: an intraindividual randomized study","volume":"19","author":"Plum","year":"1999","journal-title":"Peritoneal Dialysis International"},{"issue":"8","key":"10.1002\/14651858.CD007554.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/ndt\/12.8.1652","article-title":"In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines\/prostanoids dialysate concentrations","volume":"12","author":"Plum","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007554.pub2-BIB0148|cit148","first-page":"S80","article-title":"Effects of alternative peritoneal dialysis solutions on peritoneal transport and cytokines\/prostanoids dialysate concentrations","volume":"26","author":"Plum","year":"1997","journal-title":"Nieren-und Hochdruckkrankheiten"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/089686080702700310","article-title":"Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study","volume":"27","author":"Rodriguez-Carmona","year":"2007","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/089686080902900411","article-title":"Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis","volume":"29","author":"Sav","year":"2009","journal-title":"Peritoneal Dialysis International"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD007554.pub2-BIB0151|cit151","first-page":"vi299","article-title":"Double dose icodextrin not affect the peritoneal and systemic inflammation [abstract no: SaP201]","volume":"22","author":"Sav","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1440-1797.2009.01186.x","article-title":"Two daytime icodextrin exchanges decrease brain natriuretic peptide levels and improve cardiac functions in continuous ambulatory peritoneal dialysis patients","volume":"15","author":"Sav","year":"2010","journal-title":"Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/ndt\/gfh946","article-title":"Hypertonic glucose-based peritoneal dialysate is associated with higher blood pressure and adverse haemodynamics as compared with icodextrin","volume":"20","author":"Selby","year":"2005","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0154|cit154","first-page":"A182","article-title":"Peritoneal permeability characteristics using glycerol based dialysate in CAPD [abstract]","volume":"12","author":"Smit","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1177\/089686080002000511","article-title":"Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis","volume":"20","author":"Smit","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/089686080002000626","article-title":"A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function","volume":"20","author":"Smit","year":"2001","journal-title":"Peritoneal Dialysis International"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0157|cit157","first-page":"A233","article-title":"A comparison between 1.36% and 3.86% glucose dialysis solutions for the assessment of peritoneal membrane function [abstract]","volume":"15","author":"Smit","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0158|cit158","first-page":"iii480","article-title":"Effects of conventional versus biocompatible dialysis solutions on peritoneal and systemic inflammation, malnutrition and atherosclerosis in CAPD patients [abstract]","volume":"3","author":"Stankovic-Popovic","year":"2010","journal-title":"NDT Plus"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1046\/j.1523-1755.2000.00436.x","article-title":"Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids","volume":"58","author":"Ueda","year":"2000","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/089686080402400304","article-title":"A randomized clinical trial with a 0.6% amino acid\/ 1.4% glycerol peritoneal dialysis solution","volume":"24","author":"Biesen","year":"2004","journal-title":"Peritoneal Dialysis International"},{"issue":"11","key":"10.1002\/14651858.CD007554.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1093\/ndt\/gfn322","article-title":"Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study","volume":"23","author":"Vychytil","year":"2008","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0162|cit162","first-page":"510","article-title":"Biocompatibility of peritoneal dialysis solutions determined by genomics of human leucocytes: a cross-over study","volume":"2","author":"Wilflingseder","year":"2009","journal-title":"NDT Plus"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0163|cit163","first-page":"iii166","article-title":"The effect of low GDP solution on ultrafiltration and solute transport in CAPD patients [abstract]","author":"Cho","year":"2010","journal-title":"NDT Plus"},{"issue":"40","key":"10.1002\/14651858.CD007554.pub2-BIB0164|cit164","first-page":"2843","article-title":"Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients","volume":"90","author":"Dai","year":"2010","journal-title":"Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal]"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/089686089301300406","article-title":"Short-term clinical study with bicarbonate-containing peritoneal dialysis solution","volume":"13","author":"Feriani","year":"1993","journal-title":"Peritoneal Dialysis International"},{"issue":"Sept","key":"10.1002\/14651858.CD007554.pub2-BIB0166|cit166","first-page":"208A","article-title":"Ca125\/pai-1 ration as a marker of biocompatibility in CAPD: a prospective randomized clinical trial [abstract]","volume":"11","author":"Gesualdo","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0167|cit167","first-page":"A238","article-title":"Ca125\/pai-1 ration may be a marker of peritoneal dialysis (pd) fluids biocompatibility and membrane longevity: a clinical randomized prospective study [abstract]","volume":"15","author":"Infante","year":"2000","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0168|cit168","first-page":"131","article-title":"The effect of icodextrin dialysis solution on selected metabolic parameters in patients on continuous ambulatory peritoneal dialysis (CAPD) [abstract]","author":"Opatrna","year":"2000","journal-title":"Kidney & Blood Pressure Research"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0169|cit169","first-page":"281","article-title":"Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis","volume":"141","author":"Opatrna","year":"2002","journal-title":"Casopis Lekaru Ceskych"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ndt\/gfr244","article-title":"Effect of low-GDP bicarbonate-lactate-buffered peritoneal dialysis solutions on plasma levels of adipokines and gut appetite-regulatory peptides. A randomized crossover study","volume":"27","author":"Rodriguez-Carmona","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"September, Prog","key":"10.1002\/14651858.CD007554.pub2-BIB0171|cit171","first-page":"199A","article-title":"Dependence of ultrafiltration response to icodextrin on peritoneal membrane transport type [abstract no: F-PO684]","volume":"13","author":"Yang","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0172|cit172","unstructured":"Tam P Effect of low glucose degradation product peritoneal dialysis solution Gambrosol-Trio on residual renal function in patients receiving peritoneal dialysis - a randomized controlled trial http:\/\/www.controlled-trials.com\/ISRCTN26252543\/26252543 10.1186\/ISRCTN26252543"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3747\/pdi.2010.00234","article-title":"Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan","volume":"32","author":"Ayuzawa","year":"2012","journal-title":"Peritoneal Dialysis International"},{"issue":"10","key":"10.1002\/14651858.CD007554.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","article-title":"Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study","volume":"12","author":"Bargman","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/ndt\/gfq213","article-title":"Slouching towards Bethlehem: the beast of biocompatibility","volume":"25","author":"Bargman","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1523-1755.2002.00115.x","article-title":"AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression","volume":"61","author":"Boulanger","year":"2002","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0177|cit177","unstructured":"Brown FG Dent A Hurst K McDonald S Chapter 6: Peritoneal dialysis. In: The 34th Annual ANZDATA Report 2011 - Data to 2010 Australia &http:\/\/www.anzdata.org.au\/v1\/report_2011.html"},{"issue":"7","key":"10.1002\/14651858.CD007554.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1681\/ASN.V971285","article-title":"Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group","volume":"9","author":"Churchill","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/089686080702700207","article-title":"Status of renal replacement therapy and peritoneal dialysis in Mexico","volume":"27","author":"Cueto-Manzano","year":"2007","journal-title":"Peritoneal Dialysis International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/ndt\/13.4.962","article-title":"Peritoneal solute transport predicts survival on CAPD independently of residual renal function","volume":"13","author":"Davies","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"9","key":"10.1002\/14651858.CD007554.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1093\/ndt\/gfp313","article-title":"Preserving residual renal function in peritoneal dialysis: volume or biocompatibility?","volume":"24","author":"Davies","year":"2009","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0182|cit182","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-78940-8_11","article-title":"Chappter 11: New peritoneal dialysis solutions and solutions on the horizon","volume-title":"Nolph and Gokal's Textbook of Peritoneal Dialysis","author":"Feriani","year":"2009"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/089686089701700401","article-title":"Higher membrane permeability predicts poorer patient survival","volume":"17","author":"Fried","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"7414","key":"10.1002\/14651858.CD007554.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0185|cit185","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1797.2003.00117.x","article-title":"Recommendations for the use of icodextrin in peritoneal dialysis patients","volume":"8","author":"Johnson","year":"2003","journal-title":"Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD007554.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ki.2010.16","article-title":"Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes","volume":"77","author":"Johnson","year":"2010","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/039139889201500203","article-title":"Biocompatibility of peritoneal dialysis fluids","volume":"15","author":"Jorres","year":"1992","journal-title":"International Journal of Artificial Organs"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1046\/j.1523-1755.1998.00178.x","article-title":"Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function","volume":"54","author":"Jorres","year":"1998","journal-title":"Kidney International"},{"issue":"8","key":"10.1002\/14651858.CD007554.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.2337\/diabetes.54.8.2424","article-title":"3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells","volume":"54","author":"Justo","year":"2005","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1177\/089686080002005S06","article-title":"First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag","volume":"20 Suppl 5","author":"Lage","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1038\/ki.1995.244","article-title":"In vitro formation of advanced glycation end products in peritoneal dialysis fluid","volume":"47","author":"Lamb","year":"1995","journal-title":"Kidney International"},{"issue":"6","key":"10.1002\/14651858.CD007554.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/089686089901900605","article-title":"Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis","volume":"19","author":"Mateijsen","year":"1999","journal-title":"Peritoneal Dialysis International"},{"issue":"5","key":"10.1002\/14651858.CD007554.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1097\/01.ASN.0000060681.91079.30","article-title":"Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane","volume":"14","author":"Mortier","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/089686080402400203","article-title":"The effects of peritoneal dialysis solutions on peritoneal host defense","volume":"24","author":"Mortier","year":"2004","journal-title":"Peritoneal Dialysis International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1523-1755.2004.00879.x","article-title":"Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane","volume":"66","author":"Mortier","year":"2004","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD007554.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1523-1755.2005.00237.x","article-title":"Benefits of switching from a conventional to a low-GDP bicarbonate\/lactate-buffered dialysis solution in a rat model","volume":"67","author":"Mortier","year":"2005","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/089686080002004S02","article-title":"Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis","volume":"20 Suppl 4","author":"Mujais","year":"2000","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ki.1997.22","article-title":"Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD","volume":"51","author":"Nakayama","year":"1997","journal-title":"Kidney International"},{"issue":"3","key":"10.1002\/14651858.CD007554.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/089686089301300309","article-title":"Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes","volume":"13","author":"Nilsson-Thorell","year":"1993","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0201|cit201","article-title":"Dialysate composition in hemodialysis and peritoneal dialysis","volume-title":"Principles and Practice of Dialysis","author":"Palmer","year":"2004"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/039139880502800203","article-title":"Pathogenesis of peritoneal sclerosis","volume":"28","author":"Pollock","year":"2005","journal-title":"International Journal of Artificial Organs"},{"issue":"2","key":"10.1002\/14651858.CD007554.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3747\/pdi.2009.00264","article-title":"Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials","volume":"31","author":"Qi","year":"2011","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/ndt\/13.1.154","article-title":"Sclerosing peritonitis: the experience in Australia","volume":"13","author":"Rigby","year":"1998","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1681\/ASN.2005050566","article-title":"Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations","volume":"17","author":"Rumpsfeld","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1177\/089686089601601S24","article-title":"Effect of different buffers on the biocompatibility of CAPD solutions","volume":"16 Suppl 1","author":"Schambye","year":"1996","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0207|cit207","first-page":"42","article-title":"In vitro biocompatibility of bicarbonate-based peritoneal dialysis solutions","volume":"17","author":"Topley","year":"1997","journal-title":"Peritoneal Dialysis International"},{"issue":"11-12","key":"10.1002\/14651858.CD007554.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0021-9681(75)90076-4","article-title":"Complications of acute peritoneal dialysis","volume":"28","author":"Vaamonde","year":"1975","journal-title":"Journal of Chronic Diseases"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0209|cit209","first-page":"57","article-title":"Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid","volume":"12","author":"Wieslander","year":"1996","journal-title":"Advances in Peritoneal Dialysis"},{"issue":"84","key":"10.1002\/14651858.CD007554.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1046\/j.1523-1755.63.s84.46.x","article-title":"Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions","author":"Williams","year":"2003","journal-title":"Kidney International - Supplement"},{"issue":"11","key":"10.1002\/14651858.CD007554.pub2-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1681\/ASN.V12112434","article-title":"Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells","volume":"12","author":"Witowski","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD007554.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/089686080502503S08","article-title":"Effects of peritoneal dialysis solutions on the peritoneal membrane: clinical consequences","volume":"25 Suppl 3","author":"Witowski","year":"2005","journal-title":"Peritoneal Dialysis International"},{"issue":"1","key":"10.1002\/14651858.CD007554.pub2-BIB0213|cit213","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007554","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","author":"Wiggins","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007554.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD007554.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:26:56Z","timestamp":1648679216000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007554.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,27]]},"references-count":213,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007554.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718325956.793504519","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,27]]}}}